A controlled trial of photodynamic therapy of actinic keratosis comparing different red light sources

被引:10
|
作者
Giehl, Kathrin A. [1 ]
Kriz, Martin [1 ,2 ]
Grahovac, Maja [1 ]
Ruzicka, Thomas [1 ]
Berking, Carola [1 ]
机构
[1] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany
[2] Klinikum Augsburg, Dept Dermatol & Allergol, D-86156 Augsburg, Germany
关键词
actinic keratosis; ALA; broad-spectrum; photodynamic therapy; controlled trial; red light; NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMA; INTERNATIONAL CONSENSUS; EMITTING-DIODES; DOUBLE-BLIND; BF-200; ALA; PHASE-III; IN-VITRO; PAIN; PLACEBO;
D O I
10.1684/ejd.2014.2364
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) with red light is well established for actinic keratosis (AK). Differences have been observed concerning pain and efficacy rates with different red light sources. Objectives: To compare pain scores, short- and long-term efficacy rates of PDT of multiple AKs when employing different red light sources.. Material and methods: In a controlled trial, 88 patients (310 AK lesions) received ALA-PDT in combination with either visible light (VIS) + water-filtered infrared A (wIRA) light (PhotoDyn (R) 750 (PD750), 580-1400 nm) for 30 min or incoherent light (Waldmann (R) 1200L (Wa1200L), 600-720 nm) for 10-11 min. Followup visits were performed after 1, 3, 6, and 12 months. if there was no complete cure after 1, 3 or 6 months, a second cycle of PDT was performed. Results: Pain scores were significantly lower in patients illuminated with PD750 rather than Wa1200L. Patient complete clearance rates were 85% and 91% after 1 month, 79% and 92% after 3 months, 97% and 92% after 6 months, and 69% and 85% after 12 months in the PD750 and Wa1200L groups, respectively. Lesion complete clearance rates were 94% and 92% after 1 month, 88% and 97% after 3 months, 96% and 95% after 6 months, and 81% and 89% after 12 months in the PD750 and Wa1200L group, respectively. The efficacy rates were not significantly different. Conclusion: A VIS + wIRA light source produced considerably less pain, while efficacy was not much affected in contrast to previously published studies, probably because the illumination time was longer in this study.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [31] Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial
    Togsverd-Bo, K.
    Halldin, C.
    Sandberg, C.
    Gonzalez, H.
    Wennberg, A. M.
    Sorensen, S. S.
    Wulf, H. C.
    Haedersdal, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (04) : 903 - 909
  • [32] Pain and stinging associated with pretreatment in photodynamic therapy of actinic keratosis
    Heerfordt, Ida M.
    Wulf, Hans Christian
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2019, 25 : 225 - 226
  • [33] Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial
    Heerfordt, I. M.
    Wulf, H. C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (11) : 2058 - 2061
  • [34] Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial
    Buinauskaite, Evelina
    Zalinkevicius, Rimantas
    Buinauskiene, Jurate
    Valiukeviciene, Skaidra
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2013, 29 (04) : 173 - 181
  • [35] Daylight photodynamic therapy for actinic keratosis: Is it affected by the British weather?
    Kotb, Iman
    Lesar, Andrea
    O'Mahoney, Paul
    Eadie, Ewan
    Ibbotson, Sally H.
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2021, 37 (02) : 157 - 158
  • [36] Topical photodynamic therapy of actinic keratosis in renal transplant recipients
    Piaserico, S.
    Fortina, A. Belloni
    Rigotti, P.
    Rossi, B.
    Baldan, N.
    Alaibac, M.
    Marchini, F.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (06) : 1847 - 1850
  • [37] EMA approved new drugs: Photodynamic therapy for actinic keratosis
    Nolan, Mark
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2013, 20 (01): : 60 - 60
  • [38] Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
    Mazur, Ewelina
    Reich, Adam
    DERMATOLOGY AND THERAPY, 2023, 13 (06) : 1265 - 1276
  • [39] Important factors for pain during photodynamic therapy for actinic keratosis
    Sandberg, Carin
    Stenquist, Bo
    Rosdahl, Inger
    Ros, Anne-Marie
    Synnerstad, Ingrid
    Karlsson, Maria
    Gudmundson, Fredrik
    Ericson, Marica B.
    Larko, Olle
    Wennberg, Ann-Marie
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (05) : 404 - 408
  • [40] Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis
    Ewelina Mazur
    Adam Reich
    Dermatology and Therapy, 2023, 13 : 1265 - 1276